ROTH Capital Partners' Annual Conference is one of the largest events of its kind in the United States. Following the success of previous ROTH conferences with 500+ companies and 5,000+ attendees attending annually, this year's event will take place in a virtual format. To ensure another successful year, InvestorBrandNetwork has provided this custom-built portal for use by all the attendees who planned to return March 15-17, 2020, as well as those who follow us via our various brands. The summaries written by our team below can be used to proficiently evaluate each of the invited companies, to gain access to our market research tools, and to easily visit any company's website that attracts interest. For more information visit www.Roth.com
- A-Mark Precious Metals Inc.
- Acme United Corp.
- Acreage Holdings Inc.
- Adaptimmune Therapeutics PLC
- Adesto Technologies Corp.
- Advanced Energy Industries Inc.
- AgroFresh Solutions Inc.
- Aimmune Therapeutics Inc.
- Air Industries Group
- Airgain Inc.
- Akerna Corp.
- Akoustis Technologies Inc.
- Alarm.com Holdings Inc.
- Albireo Pharma Inc.
- Alexco Resource Corp.
- Alico Inc.
- Allied Esports Entertainment Inc.
- Allied Motion Technologies Inc.
- Alpha and Omega Semiconductor Ltd.
- Altimmune Inc.
- Ambarella Inc.
- Ameresco Inc.
- American Outdoor Brands Corp.
- American Superconductor Corp.
- American Vanguard Corp.
- Americas Gold and Silver Corp.
- Ampio Pharmaceuticals Inc.
- Amplify Energy Corp.
- Amtech Systems Inc.
- Amyris Inc.
- Applied Genetic Technologies Corp.
- Applied DNA Sciences Inc.
- Aptevo Therapeutics Inc.
- Arcimoto Inc.
- Arcturus Therapeutics Holdings Inc.
- Aridis Pharmaceuticals Inc.
- Artelo Biosciences Inc.
- Ascot Resources Ltd.
- Aspen Group Inc.
- Assure Holdings Corp.
- Asure Software Inc.
- Atomera Inc.
- aTyr Pharma Inc.
- Auryn Resources Inc.
- Avalon GloboCare Corp.
- Ayr Strategies Inc.
- Azure Power Global Limited
- AzurRx BioPharma Inc.
- Ballard Power Systems Inc.
- Barrett Business Services Inc.
- Bellerophon Therapeutics Inc.
- Better Choice Company Inc.
- Beyond Air Inc.
- BG Staffing Inc.
- Biocept Inc.
- Bioceres Crop Solutions Corp.
- BioDelivery Sciences International Inc.
- Bionano Genomics Inc.
- BioSig Technologies Inc.
- BlackRidge Technology International Inc.
- Blink Charging Co.
- Blue Bird Corp.
- Body and Mind Inc.
- Boingo Wireless Inc.
- Brickell Biotech Inc.
- Broadwind Energy Inc.
- Burcon NutraScience Corp.
- CalAmp Corp.
- Callaway Golf Company
- Calyxt Inc.
- Cambium Networks Corp.
- Canadian Solar Inc.
- Canterbury Park Holding Corp.
- Carriage Services Inc.
- cbdMD Inc.
- CECO Environmental Corp.
- Cellectar Biosciences Inc.
- Celsion Corp.
- Celsius Holdings Inc.
- Century Casinos Inc.
- Cerence Inc.
- CEVA Inc.
- Champions Oncology Inc.
- Chaparral Energy Inc.
- Charles & Colvard Ltd.
- Charles River Associates
- Charlotte's Web Holdings Inc.
- Chiasma Inc.
- China Online Education Group
- ChromaDex Corp.
- CIM Commercial Trust Corp.
- Clarus Corp.
- Clearfield Inc.
- ClearOne Inc.
- Clearside Biomedical Inc.
- Codexis Inc.
- CNFinance Holdings Ltd.
- CNS Pharmaceuticals Inc.
- CohBar Inc.
- Columbia Care Inc.
- Compass Diversified Holdings
- Consolidated Water Co. Ltd.
- Converge Technology Solutions Corp.
- Conversion Labs Inc.
- Cooper-Standard Holdings Inc.
- CoreCivic Inc.
- Corvus Gold Inc.
- Corvus Pharmaceuticals Inc.
- Covanta Holding Corp.
- Cree Inc.
- Cresco Labs Inc.
- Crinetics Pharmaceuticals Inc.
- Crown Crafts Inc.
- Cryoport Inc.
- Curaleaf Holdings Inc.
- CV Sciences Inc.
- Cyclacel Pharmaceuticals Inc.
- CynergisTek Inc.
- Daqo New Energy Corp.
- Daré Bioscience Inc.
- Darling Ingredients Inc.
- Delcath Systems Inc.
- Delta Apparel Inc.
- DHI Group Inc.
- DiaMedica Therapeutics Inc.
- Digi International Inc.
- Digital Turbine Inc.
- DMC Global Inc.
- DSP Group Inc.
- Dyadic International Inc.
- Earthstone Energy Inc.
- Eastside Distilling Inc.
- Edesa Biotech Inc.
- eGain Communications Corp.
- Eldorado Resorts Inc.
- electroCore Inc.
- ElectraMeccanica Vehicles Corp.
- Elixinol Global Ltd.
- Emerald Bioscience Inc.
- Emmaus Life Sciences Inc.
- Endeavour Silver Corp.
- Energous Corp.
- Energy Fuels Inc.
- Enphase Energy Inc.
- EnviroLeach Technologies Inc.
- Envision Solar International Inc.
- EnWave Corp.
- Epsilon Energy Ltd.
- Escalade Sports Inc.
- Everi Holdings Inc.
- Evolution Petroleum Corp.
- Extreme Networks Inc.
- EyeGate Pharmaceuticals Inc.
- Eyenovia Inc.
A-Mark Precious Metals Inc. (NASDAQ: AMRK)
A-Mark Precious Metals (NASDAQ: AMRK) is a leading full-service precious metals trading company and wholesaler of gold, silver, platinum and palladium bullion and related products. The company's global customer base includes sovereign and private mints, manufacturers and fabricators, refiners, dealers, financial institutions, industrial users, investors, collectors, and e-commerce and other retail customers. The company conducts its operations through three complementary segments: Wholesale Trading & Ancillary Services, Secured Lending, and Direct Sales. For more information, visit the company's website at www.amark.com
Acme United Corp. (NYSE: ACU)
Acme United (NYSE: ACU) is a leading global supplier of innovative first aid, safety and cutting products for the school, home, office, hardware and industrial markets. The company's leading brands include First Aid Only, PhysiciansCare, Pac-Kit, Spill Magic, Westcott, Clauss, Camillus, Cuda and DMT. Acme United aims to be the leading supplier of cutting, measuring and safety products to businesses, schools and homes worldwide; to be known for quality and innovation in all the categories in which it participates; and to enter new categories, offering innovation that surpasses the competition. For more information, visit the company's website at www.acmeunited.ca
Acreage Holdings Inc. (CSE: ACRG.U) (OTCQX: ACRGF)
Acreage Holdings (CSE: ACRG.U) (OTCQX: ACRGF) is one of the largest vertically integrated, multi-state operators of cannabis licenses and assets in the United States. Acreage owns licenses to operate or has management or consulting services or other agreements in place with license holders to assist in operations in 20 states (including pending acquisitions) with a population of approximately 180 million Americans, and an estimated 2022 total addressable market of $16.7 billion in legal cannabis sales. Acreage is dedicated to building and scaling operations to create a seamless, consumer-focused branded cannabis experience. Acreage's national retail store brand, The Botanist, debuted in 2018. For more information, visit the company's website at www.acreageholdings.com
Adaptimmune Therapeutics PLC (NASDAQ: ADAP)
Adaptimmune Therapeutics (NASDAQ: ADAP) is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer. The company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors. Adaptimmune has clinical trials ongoing for three wholly owned SPEAR T-cells—ADP-A2M4 (MAGE-A4), ADP-A2M10 (MAGE-A10) and ADP-A2AFP (AFP)—in multiple solid tumor indications. For more information, visit the company's website at www.adaptimmune.com
Adesto Technologies Corp. (NASDAQ: IOTS)
Adesto Technologies (NASDAQ: IOTS) is a leading provider of innovative application-specific semiconductors and embedded systems for the IoT. The company's technology is used by more than 5,000 customers worldwide who are creating differentiated solutions across industrial, consumer, medical and communications markets. With its growing portfolio of high-value technologies, Adesto is helping its customers usher in the era of the Internet of Things. For more information, visit the company's website at www.adestotech.com
Advanced Energy Industries Inc. (NASDAQ: AEIS)
Advanced Energy (NASDAQ: AEIS) is a global leader in the design and manufacturing of highly engineered, precision power conversion, measurement and control solutions for mission-critical applications and processes. AE's power solutions enable customer innovation in complex applications for a wide range of industries including semiconductor equipment, industrial, manufacturing, telecommunications, data center computing and health care. With engineering know-how and responsive service and support around the globe, the company builds collaborative partnerships to meet technology advances, propel growth for its customers and innovate the future of power. Advanced Energy has devoted more than three decades to perfecting power for its global customers and is headquartered in Fort Collins, Colorado. For more information, visit the company's website at www.advancedenergy.com
AgroFresh Solutions Inc. (NASDAQ: AGFS)
AgroFresh Solutions (NASDAQ: AGFS) is a leading global innovator and provider of science-based solutions, data-driven technologies and experience-backed services to enhance the quality and extend the shelf life of fresh produce. For more than 20 years, AgroFresh has been revolutionizing the apple industry and has launched new innovative solutions in a variety of fresh produce categories, from bananas to cherries and citrus to pears. AgroFresh supports growers, packers and retailers by providing near- and post-harvest solutions across the industry to enhance crop values while conserving our planet's resources and reducing global food waste. For more information, visit the company's website at www.agrofresh.com
Aimmune Therapeutics Inc. (NASDAQ: AIMT)
Aimmune Therapeutics (NASDAQ: AIMT) is a biopharmaceutical company that aspires to become the global leader in developing curative therapies and solutions for patients with food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The company's Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to treat other food allergies. For more information, visit the company's website at www.aimmune.com
Air Industries Group (NYSE: AIRI)
Air Industries Group (NYSE: AIRI) is an integrated manufacturer of complex machined products, including landing gear, flight control and jet turbine components for leading aerospace and defense prime contractors. Air Industries Group is comprised of two sectors: complex machining and turbine engine. Comprised of two facilities in New York and Connecticut, Air Industries Group provides a one-stop solution for products ranging from components to integrated assemblies. The company's core competencies include complex machining, fixtured assemblies and deep hole drilling. For more information, visit the company's website at www.airindustriesgroup.com
Airgain Inc. (NASDAQ: AIRG)
Airgain (NASDAQ: AIRG) is a leading provider of advanced antenna technologies used to enable high-performance wireless networking across a broad range of devices and markets, including consumer, enterprise and automotive. Combining design-led thinking with testing and development, Airgain works in partnership with the entire ecosystem, including carriers, chipset suppliers, OEMs and ODMs. Airgain's antennas are deployed in carrier, fleet, enterprise, residential, private, government and public safety wireless networks and systems, including set-top boxes, access points, routers, modems, gateways, media adapters, portables, digital televisions, sensors, fleet, and asset tracking devices. Airgain is headquartered in San Diego, California, and maintains design and test centers in the U.S., U.K. and China. For more information, visit the company's website at www.airgain.com
Akerna Corp. (NASDAQ: KERN)
Akerna (NASDAQ: KERN) is a global regulatory compliance technology company in the cannabis space. Akerna's service offerings include MJ Platform®, Leaf Data Systems®, and solo sciences tech platform. Since its establishment in 2010, the company has tracked more than $17 billion in cannabis sales. As part of its business strategy, Akerna intends to grow through targeted, strategic acquisitions that are complementary to its current business and organically by accelerating its product development efforts. Akerna is based in Denver. For more information, visit the company's website at www.akerna.com
Akoustis Technologies Inc. (NASDAQ: AKTS)
Akoustis Technologies (NASDAQ: AKTS) is a high-tech BAW RF filter solutions company pioneering next-generation materials science and MEMS wafer manufacturing to address the market requirements for improved RF filters – targeting higher bandwidth, higher operating frequencies and higher output power compared to incumbent polycrystalline BAW technology deployed today. The company utilizes its proprietary XBAW manufacturing process to produce bulk acoustic wave RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. Superior performance is driven by the significant advances of high-purity, single-crystal and associated piezoelectric materials and the resonator-filter process technology, which drives electro-mechanical coupling and translates to wide filter bandwidth. For more information, visit the company's website at www.akoustis.com
Alarm.com Holdings Inc. (NASDAQ: ALRM)
Alarm.com Holdings (NASDAQ: ALRM) is a leading platform for the intelligently connected property. Millions of consumers and businesses depend on Alarm.com's technology to manage and control their property from anywhere. The company's platform integrates with a growing variety of Internet of Things (IoT) devices through apps and interfaces. Alarm.com's security, video, access control, intelligent automation, energy management, and wellness solutions are available through the company's network of thousands of professional service providers in North America and around the globe. For more information, visit the company's website at www.alarm.com
Albireo Pharma Inc. (NASDAQ: ALBO)
Albireo Pharma (NASDAQ: ALBO) is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases and is in phase 3 development in its initial target indication, progressive familial intrahepatic cholestasis (PFIC). Albireo's clinical pipeline also includes two phase 2 product candidates. Elobixibat is in phase 2 development in NAFLD and NASH. Approved in Japan for the treatment of chronic constipation, elobixibat is the first ileal bile acid transporter (IBAT) inhibitor approved anywhere in the world. For more information, visit the company's website at www.albireopharma.com
Alexco Resource Corp. (TSX: AXU) (NYSE: AXU)
Alexco Resource (TSX: AXU) (NYSE: AXU) is a Canadian primary silver company that owns the majority of the historic high-grade Keno Hill Silver District in Canada's Yukon Territory. Alexco has a long history of expanding Keno Hill's mineral resources through successful exploration and is currently advancing a development plan for the District. In 2019, the company published a positive pre-feasibility study that estimates production of 1.12 million tonnes of ore at an average rate of 430 tonnes per day at an average grade of 805 grams per tonne silver over an eight-year mine life from the Flame & Moth, Bermingham, Bellekeno and Lucky Queen deposits. Alexco is advancing key surface infrastructure while it awaits the final permit to make a positive construction decision. For more information, visit the company's website at www.alexcoresource.com
Alico Inc. (NASDAQ: ALCO)
Alico (NASDAQ: ALCO) is a holding company with assets and related operations in agriculture and environmental resources, including citrus, wildlife management and water management. The company's mission is to create value for shareholders by managing existing assets to their optimal current income and total returns, opportunistically acquiring new assets, and producing high-quality agricultural products while exercising responsible environmental stewardship. Alico's objectives are to produce the highest-quality agriculture products; create innovative land uses; opportunistically acquire and convert undervalued assets; sell under-productive land; generate recurring and sustainable profit with the appropriate balance of risk and reward; and exceed the expectations of shareholders, customers, clients, growers and partners. For more information, visit the company's website at www.alicoinc.com
Allied Esports Entertainment Inc. (NASDAQ: AESE)
Allied Esports Entertainment (NASDAQ: AESE) is a global esports entertainment venture dedicated to providing transformative live experiences, multiplatform content, and interactive services to audiences worldwide through its strategic fusion of two powerful entertainment brands: Allied Esports and the World Poker Tour (WPT). The award-winning company is comprised of a global network of dedicated esports properties and content production facilities. Its mission is to connect players, streamers and fans around the world through integrated arenas, including its flagship venue, HyperX Esports Arena Las Vegas; its fleet of mobile esports trucks, the HyperX Esports Trucks; and affiliate members of the Allied Esports Property Network, which serve as both competition battlegrounds and everyday content generation hubs. For more information, visit the company's website at www.alliedesports.gg
Allied Motion Technologies Inc. (NASDAQ: AMOT)
Allied Motion Technologies (NASDAQ: AMOT) designs, manufactures and sells precision and specialty controlled-motion products and solutions used in a broad range of industries within its major served markets, which include vehicle, medical, aerospace & defense, and industrial. The company is focused on controlled motion applications and is known worldwide for its expertise in electromagnetic, mechanical and electronic motion technology. Its products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gear motors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues, and other controlled motion-related products. For more information, visit the company's website at www.alliedmotion.com
Alpha and Omega Semiconductor Ltd. (NASDAQ: AOSL)
Alpha and Omega Semiconductor (NASDAQ: AOSL) is a designer, developer and global supplier of a broad range of power semiconductors, including a wide portfolio of Power MOSFET, IGBT, IPM, TVS, HVIC, GaN/SiC, Power IC and Digital Power products. AOS has developed extensive intellectual property and technical knowledge that encompasses the latest advancements in the power semiconductor industry, which enables the company to introduce innovative products to address the increasingly complex power requirements of advanced electronics. AOS differentiates itself by integrating its Discrete and IC semiconductor process technology, product design, and advanced packaging know-how to develop high performance power management solutions. For more information, visit the company's website at www.aosmd.com
Altimmune Inc. (NASDAQ: ALT)
Altimmune (NASDAQ: ALT) is a clinical-stage biopharmaceutical company focused on developing treatments for liver diseases and immune modulating therapies. The company's diverse pipeline includes next-generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™), conjugated immunostimulants for the treatment of cancer (ALT-702), and intranasal vaccines (NasoShield™ and NasoVAX™). For more information, visit the company's website at www.altimmune.com
Ambarella Inc. (NASDAQ: AMBA)
Ambarella (NASDAQ: AMBA) offers products that are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving, and robotic applications. Ambarella's low-power system on chips (SoCs) offer high-resolution video compression, advanced image processing, and powerful deep neural network processing to enable intelligent cameras to extract valuable data from high-resolution video streams. For more information, visit the company's website at www.ambarella.com
Ameresco Inc. (NYSE: AMRC)
Ameresco (NYSE: AMRC) is a leading independent provider of comprehensive services, energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions for businesses and organizations throughout North America and Europe. Ameresco's sustainability services include upgrades to a facility's energy infrastructure and the development, construction and operation of renewable energy plants. Ameresco has successfully completed energy-saving, environmentally responsible projects with federal, state and local governments; health care and educational institutions; housing authorities; and commercial and industrial customers. With its corporate headquarters in Framingham, Massachusetts, Ameresco has more than 1,000 employees providing local expertise in the United States, Canada and the United Kingdom. For more information, visit the company's website at www.ameresco.com
American Outdoor Brands Corp. (NASDAQ: AOBC)
American Outdoor Brands (NASDAQ: AOBC) is a provider of quality products for shooting, hunting and rugged outdoor enthusiasts in the global consumer and professional markets. The company reports two segments: Firearms and Outdoor Products & Accessories. Firearms manufactures handgun, long gun and suppressor products sold under the iconic Smith & Wesson, M&P, Thompson/Center Arms, and Gemtech brands. AOB Outdoor Products & Accessories is an industry leading provider of shooting, reloading, gunsmithing and gun cleaning supplies, specialty tools and cutlery, and electro-optics products and technology for firearms. For more information, visit the company's website at www.aob.com
American Superconductor Corp. (NASDAQ: AMSC)
American Superconductor (NASDAQ: AMSC) generates the ideas, technologies and solutions that meet the world's demand for smarter, cleaner, better energy. Through its Gridtec™ Solutions, AMSC provides the engineering planning services and advanced grid systems that optimize network reliability, efficiency and performance. Through its Windtec™ Solutions, AMSC provides wind turbine electronic controls and systems, designs and engineering services that reduce the cost of wind energy. The company's solutions are now powering gigawatts of renewable energy globally and are enhancing the performance and reliability of power networks in more than a dozen countries. Founded in 1987, AMSC is headquartered near Boston, Massachusetts, with operations in Asia, Australia, Europe and North America. For more information, visit the company's website at www.amsc.com
American Vanguard Corp. (NYSE: AVD)
American Vanguard (NYSE: AVD) is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor's Small Cap 600 Index. For more information, visit the company's website at www.american-vanguard.com
Americas Gold and Silver Corp. (TSX: USA) (NYSE: USAS)
Americas Gold and Silver (TSX: USA) (NYSE: USAS) is a high-growth precious metals mining company with multiple assets in North America. The company's newest asset, Relief Canyon in Nevada, has poured first gold and is expected to ramp up to full production over the course of 2020. The company also owns and operates the Cosalá Operations in Sinaloa, Mexico, and manages the 60%-owned Galena Complex in Idaho. The company also holds an option on the San Felipe development project in Sonora, Mexico. For additional information, visit the company's website at www.americas-gold.com
Ampio Pharmaceuticals Inc. (NYSE: AMPE)
Ampio Pharmaceuticals (NYSE: AMPE) is a development-stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. The company is developing compounds that serve significant medical needs in osteoarthritis, diabetic macular edema and other prevalent, inflammatory diseases through an innovative discovery and development platform. For more information, visit the company's website at www.ampiopharma.com
Amplify Energy Corp. (NYSE: AMPY)
Amplify Energy (NYSE: AMPY) is an independent oil and natural gas company engaged in the acquisition, development, exploration and production of oil and natural gas properties. The company's properties consist of mature, legacy oil and natural gas fields. Amplify is focused on maintaining production across its high-quality asset base and executing on its strategic priorities. Amplify's operations are focused in Oklahoma, east Texas/north Louisiana, offshore California, the Rockies and south Texas. For more information, visit the company's website at www.amplifyenergy.com
Amtech Systems Inc. (NASDAQ: ASYS)
Amtech Systems (NASDAQ: ASYS) is a leading global manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies and light-emitting diodes (LEDs). The company sells these products to semiconductor and automotive component manufacturers worldwide, particularly in Asia, North America and Europe. Amtech's strategic focus is on semiconductor growth opportunities in power electronics, leveraging its strength in its core competencies in thermal and substrate processing. Amtech is a market leader in the high-end power chip market (SiC and 300mm silicon horizontal thermal reactor), developing and supplying essential equipment and consumables used in the semiconductor industry. Amtech's products are recognized under the leading brand names BTU International, Bruce TechnologiesTM and PR HoffmanTM. For more information, visit the company's website at www.amtechsystems.com
Amyris Inc. (NASDAQ: AMRS)
Amyris (NASDAQ: AMRS) is a science and technology leader in the research, development and production of pure, sustainable ingredients for the health & wellness, clean beauty, and flavors & fragrances markets. Amyris applies its exclusive advanced technology, including state-of-the-art machine learning, robotics and artificial intelligence, to engineer yeast, which, when combined with sugarcane syrup through fermentation, is converted to highly pure molecules for specialty ingredients. Amyris manufactures sustainably sourced ingredients at industrial scale for B2B partners and further distribution to over 3,000 of the world's top brands, reaching more than 200 million consumers. Amyris also owns the Biossance consumer brand – the fastest-growing clean skincare brand in the U.S. For more information, visit the company's website at www.amyris.com
Applied Genetic Technologies Corp. (NASDAQ: AGTC)
Applied Genetic Technologies (NASDAQ: AGTC) is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's initial focus is in the field of ophthalmology, where it has active clinical trial programs in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 & ACHM CNGA3). In addition to its clinical trials, AGTC has preclinical programs in optogenetics, otology and adrenoleukodystrophy (ALD), frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which are diseases of the central nervous system (CNS), and other ophthalmology indications. AGTC has a significant intellectual property portfolio and extensive expertise in the design of gene therapy products including capsids, promoters and expression cassettes, as well as expertise in the formulation, manufacture and physical delivery of gene therapy products. For more information, visit the company's website at www.agtc.com
Applied DNA Sciences Inc. (NASDAQ: APDN)
Applied DNA Sciences (NASDAQ: APDN) is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates. Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. For more information, visit the company's website at www.adnas.com
Aptevo Therapeutics Inc. (NASDAQ: APVO)
Aptevo Therapeutics (NASDAQ: APVO) is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients' lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of hemophilia B; and a versatile core technology: the ADAPTIR™ modular protein technology platform, capable of generating highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer. For more information, visit the company's website at www.aptevotherapeutics.com
Arcimoto Inc. (NASDAQ: FUV)
Arcimoto (NASDAQ: FUV) is devising new technologies and patterns of mobility that raise the bar for environmental efficiency, footprint and affordability. Available for pre-order today, Arcimoto's Fun Utility Vehicle, Rapid Responder and Deliverator are some of the lightest, most affordable and most appropriate electric vehicles, suitable for everyday transport. Acrimoto is headquartered in Eugene, Oregon. For more information, visit the company's website at www.arcimoto.com
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT)
Arcturus Therapeutics (NASDAQ: ARCT) is an RNA medicines company with enabling technologies – LUNAR® lipid-mediated delivery, Unlocked Nucleomonomer Analog (UNA) chemistry, STARR technology™ – and mRNA drug substance along with drug product manufacturing. Arcturus' diverse pipeline of RNA therapeutics includes programs to potentially treat ornithine transcarbamylase (OTC) deficiency, cystic fibrosis, glycogen storage disease ype 3, hepatitis B and nonalcoholic steatohepatitis (NASH). Arcturus' versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, DNA and gene editing therapeutics. Arcturus' technologies are covered by its extensive patent portfolio (182 patents and patent applications issued in the U.S., Europe, Japan, China and other countries). For more information, visit the company's website at www.Arcturusrx.com
Aridis Pharmaceuticals Inc. (NASDAQ: ARDS)
Aridis Pharmaceuticals (NASDAQ: ARDS) discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The company is utilizing its proprietary APEX™ and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection and to manufacture mAbs for therapeutic treatment of critical infections. These mAbs are already of human origin and functionally optimized for high potency by the donor's immune system; hence, they do not require genetic engineering or further optimization to achieve full functionality. The company has generated multiple clinical stage mAbs targeting bacteria that cause life-threatening infections such as VAP and HAP. For more information, visit the company's website at www.aridispharma.com
Artelo Biosciences Inc. (NASDAQ: ARTL)
Artelo Biosciences (NASDAQ: ARTL) is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading-edge scientific, regulatory and commercial discipline to develop high-impact therapies. For more information, visit the company's website at www.artelobio.com
Ascot Resources Ltd. (TSX: AOT) (OTCQX: AOTVF)
Ascot Resources (TSX: AOT) (OTCQX: AOTVF) is a Canada-based junior exploration company focused on re-starting the past producing historic Premier gold mine, located in British Columbia's Golden Triangle. The company continues to define high-grade resources for underground mining with the near-term goal of converting the underground resources into reserves, while continuing to explore nearby targets on its Premier/Dilworth and Silver Coin properties (collectively referred to as the Premier Gold Project). Ascot's acquisition of IDM Mining added the high-grade gold and silver Red Mountain Project to its portfolio and positions the company as a leading consolidator of high-quality assets in the Golden Triangle. For more information, visit the company's website at www.ascotgold.com
Aspen Group Inc. (NASDAQ: ASPU)
Aspen Group (NASDAQ: ASPU) is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. Having accumulated decades of collective experience across a variety of fields, Aspen Group's leadership team is the source of the company's success. For more information, visit the company's website at www.aspu.com
Assure Holdings Corp. (TSXV: IOM) (OTCQB: ARHH)
Assure Holdings (TSX.V: IOM) (OTCQB: ARHH) is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission's Gold Seal of Approval®. For more information, visit the company's website at www.assureneuromonitoring.com
Asure Software Inc. (NASDAQ: ASUR)
Asure Software (NASDAQ: ASUR) sees human capital management (HCM) through the lens of entrepreneurs and executives with an owner's mentality. The company helps more than 60,000 small and mid-sized businesses develop their "human capital" to get to the next level, remain compliant, and allocate their time, money and technology toward growth. Asure's HCM solution includes Asure Payroll & Tax, Asure HR, and Asure Time & Attendance. The company's Asure HRServices offering ranges from online compliance tools to a fully outsourced HR department. For more information, visit the company's website at www.asuresoftware.com
Atomera Inc. (NASDAQ: ATOM)
Atomera (NASDAQ: ATOM) is a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ ("MST®"), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano¬scaling technologies already in the semiconductor industry roadmap. For more information, visit the company's website at www.atomera.com
aTyr Pharma Inc. (NASDAQ: LIFE)
aTyr Pharma (NASDAQ: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. aTyr's research and development efforts are concentrated on a newly discovered area of biology: the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr's primary focus is ATYR1923, a clinical-stage product candidate that binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. For more information, visit the company's website at www.atyrpharma.com
Auryn Resources Inc. (TSX: AUG) (NYSE: AUG)
Auryn Resources (TSX: AUG) (NYSE: AUG) is a technology-driven junior exploration company focused on finding and advancing globally significant precious and base metal deposits. The company has a portfolio approach to asset acquisition and has seven projects, including two flagships: the Committee Bay high-grade gold project in Nunavut and the Sombrero copper-gold project in southern Peru. Auryn's technical and management teams have an impressive track record of successfully monetizing assets for all stakeholders and local communities in which it operates. Auryn conducts itself to the highest standards of corporate governance and sustainability. For more information, visit the company's website at www.aurynresources.com
Avalon GloboCare Corp. (NASDAQ: AVCO)
Avalon GloboCare (NASDAQ: AVCO) is a clinical-stage, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative exosome technologies and cellular therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth, development and competitiveness in health care and CellTech industry markets. Through its subsidiary structure with unique integration of verticals, from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of in vitro diagnostics (''liquid biopsy''), immune effector cell therapy (including CAR-T/CAR-NK), and regenerative therapeutics. For more information, visit the company's website at www.avalon-globocare.com
Ayr Strategies Inc. (CSE: AYR.A) (OTCQX: AYRSF)
Ayr Strategies (CSE: AYR.A) (OTCQX: AYRSF) is a vertically integrated multistate operator in the U.S. cannabis sector, with an initial anchor portfolio in Massachusetts and Nevada. Through its operating companies, Ayr is a leading cultivator, manufacturer and retailer of cannabis products and branded cannabis packaged goods. Ayr seeks to create regional clusters in core geographies for future expansion while pursuing strong organic growth within its existing portfolio. For more information, visit the company's website at www.ayrstrategies.com
Azure Power Global Limited (NYSE: AZRE)
Azure Power Global (NYSE: AZRE) is a leading independent solar power producer with a pan-India portfolio. With its in-house engineering, procurement and construction expertise and advanced in-house operations and maintenance capability, Azure Power provides low-cost and reliable solar power solutions to customers throughout India. The company has developed, constructed and operated solar projects of varying sizes since its inception in 2008. For more information, visit the company's website at www.azurepower.com
AzurRx BioPharma Inc. (NASDAQ: AZRX)
AzurRx BioPharma (NASDAQ: AZRX) is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. MS1819 recombinant lipase for EPI is the company's lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infections. The company is headquartered in Brooklyn, New York, with scientific operations based in Langlade, France. For more information, visit the company's website at www.azurrx.com
Ballard Power Systems Inc. (TSX: BLDP) (NASDAQ: BLDP)
Ballard Power Systems (TSX: BLDP) (NASDAQ: BLDP) aims to be the leading global provider of innovative clean energy solutions, offering superior performance at a reduced operating cost. The company operates with a vision of delivering fuel cell power for a sustainable planet. Ballard zero-emission PEM fuel cells are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, passenger cars, forklift trucks and UAVs. For more information, visit the company's website at www.ballard.com
Barrett Business Services Inc. (NASDAQ: BBSI)
Barrett Business Services (NASDAQ: BBSI) is a leading provider of business management solutions, combining human resource outsourcing and professional management consulting to create a unique operational platform that differentiates it from competitors. The company's integrated platform is built upon expertise in payroll processing, employee benefits, workers' compensation coverage, risk management and workplace safety programs, and human resource administration. BBSI's partnerships help businesses of all sizes improve the efficiency of their operations. The company works with more than 6,400 clients across all lines of business in 23 states. For more information, visit the company's website at www.mybbsi.com
Bellerophon Therapeutics Inc. (NASDAQ: BLPH)
Bellerophon Therapeutics (NASDAQ: BLPH) is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The company is currently developing multiple product candidates under its INOpulse® program, a proprietary pulsatile nitric oxide delivery system. For more information, visit the company's website at www.bellerophon.com
Better Choice Company Inc. (OTCQB: BTTR)
Better Choice Company (OTCQB: BTTR) is an animal health and wellness company founded on the belief that good health practices and nutrition contribute to, and promote, a higher quality of life. The company has built a portfolio of global animal wellness brands, including TruPet; TruGold; and Halo, Purely for Pets®. BTTR's core product lines comprise ultra-premium, all-natural pet food, treats and supplements, with a special focus on freeze-dried and dehydrated raw products. For more information, visit the company's website at www.betterchoicecompany.com
Beyond Air Inc. (NASDAQ: XAIR)
Beyond Air (NASDAQ: XAIR) is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System, LungFit™, that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of various pulmonary diseases. The LungFit ™ can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. For more information, visit the company's website at www.beyondair.net
BG Staffing Inc. (NYSE: BGSF)
BG Staffing (NYSE: BGSF) provides workforce solutions to a variety of industries through its various divisions in IT, cyber, finance & accounting, creative, real estate (apartment communities and commercial buildings), and light industrial. BGSF has integrated several regional and national brands, achieving scalable growth. The company was ranked by Staffing Industry Analysts as the 64th largest U.S. staffing company in the 2019 update and the 45th largest IT staffing firm in 2018. The company's disciplined acquisition philosophy has resulted in a seasoned management team with strong tenure and the ability to offer exceptional service to its field talent and client partners while building value for investors. For more information, visit the company's website at www.bgstaffing.com
Biocept Inc. (NASDAQ: BIOC)
Biocept (NASDAQ: BIOC) is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The company uses its proprietary liquid biopsy technology to provide physicians with information for treating and monitoring patients diagnosed with cancer. The company's patented Target Selector liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in plasma (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient's disease and therapeutic options. For more information, visit the company's website at www.biocept.com
Bioceres Crop Solutions Corp. (NYSE: BIOX)
Bioceres Crop Solutions (NYSE: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture toward carbon neutrality. To do this, Bioceres' solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next-generation crop nutrition and protection solutions. Through its HB4® program, the company is bringing digital solutions to support growers' decisions and provide end-to-end traceability for production outputs. For more information, visit the company's website at www.investors.biocerescrops.com
BioDelivery Sciences International Inc. (NASDAQ: BDSI)
BioDelivery Sciences International (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain, opioid dependence and opioid-induced constipation. For more information, visit the company's website at www.bdsi.com
Bionano Genomics Inc. (NASDAQ: BNGO)
Bionano Genomics (NASDAQ: BNGO) is a life sciences instrumentation company in the genome analysis space. Bionano develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to drive the adoption of digital cytogenetics, which is designed to be a more systematic, streamlined and industrialized form of traditional cytogenetics. The Saphyr system comprises an instrument, chip consumables, reagents and a suite of data analysis tools. For more information, visit the company's website at www.bionanogenomics.com
BioSig Technologies Inc. (NASDAQ: BSGM)
BioSig Technologies (NASDAQ: BSGM) is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. Led by a proven management team and a veteran board of directors, BioSig Technologies is preparing to commercialize its PURE EP™ System. The technology has been developed to address an unmet need in a large and growing market. The company's first product, PURE EP™ System, is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. For more information, visit the company's website at www.biosig.com
BlackRidge Technology International Inc. (OTCQB: BRTI)
BlackRidge Technology International (OTCQB: BRTI) enables its customers and partners to deliver more secure and resilient business services in today's rapidly evolving cyberthreat environments. The company's zero-trust approach to adaptive cyber defense proactively protects cloud services, servers and IoT devices, and microsegments networks. The company's patented technology authenticates user or device identity and enforces security policy on the first packet of network sessions. This new level of real-time protection blocks or redirects unidentified and unauthorized traffic to stop port scanning, cyberattacks and unauthorized access. BlackRidge was founded in 2010 to commercialize its military-grade and patented network security technologies. For more information, visit the company's website at www.blackridge.us
Blink Charging Co. (NASDAQ: BLNK)
Blink Charging (NASDAQ: BLNK) is a leading owner/operator of EV charging stations in the United States with a growing presence in Europe, Asia, Israel, the Caribbean and South America. With a long history as a pioneer in the EV industry and a dedicated team with immense knowledge of the industry, Blink continues to be the preferred, trusted partner in EV charging station technology. As such, the company is a driving force with more than 150,000 registered EV driver members and more than 15,000 EV charging stations deployed. For more information, visit the company's website at www.blinkcharging.com
Blue Bird Corp. (NASDAQ: BLBD)
Blue Bird (NASDAQ: BLBD) is the leading independent designer and manufacturer of school buses, with more than 570,000 buses sold since its formation in 1927 and approximately 180,000 buses in operation today. Blue Bird's longevity and reputation in the school bus industry have made it an iconic American brand. Blue Bird distinguishes itself from its principal competitors by its singular focus on the design, engineering, manufacture and sale of school buses and related parts. As the only manufacturer of chassis and body production specifically designed for school bus applications, Blue Bird is recognized as an industry leader for school bus innovation, safety, product quality/reliability/durability, operating costs and drivability. Blue Bird is additionally the market leader in alternative fuel applications with its propane-powered and compressed natural gas-powered school buses. For more information, visit the company's website at www.blue-bird.com
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ)
Body and Mind (CSE: BAMM) (OTCQB: BMMJ) invests in high-quality medical and recreational cannabis cultivation, production and retail. The company's wholly owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licenses and holds cultivation and production licenses. BaM products include dried flower, edibles, oils and extracts as well as GPEN Gio cartridges. BaM cannabis strains have won numerous awards. BaM continues to expand operations in Nevada, California, Arkansas and Ohio and is dedicated to increasing shareholder value by focusing time and resources on improving operational efficiencies, facility expansions, state licensing opportunities as well as mergers and acquisitions. For more information, visit the company's website at www.bamcannabis.com
Boingo Wireless Inc. (NASDAQ: WIFI)
Boingo Wireless (NASDAQ: WIFI) is the leading DAS and Wi-Fi provider that serves consumers, carriers and advertisers worldwide. The company helps the world stay connected. Its vast footprint of DAS, Wi-Fi and small cells reaches more than a billion people annually, making Boingo one of the largest providers of indoor wireless networks. Boingo can be found connecting people and things at airports, stadiums, military bases, convention centers, multifamily communities and commercial properties. For more information, visit the company's website at www.boingo.com
Brickell Biotech Inc. (NASDAQ: BBI)
Brickell Biotech (NASDAQ: BBI) is a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases. Brickell's pipeline consists of potential novel therapeutics for hyperhidrosis, cutaneous T-cell lymphoma, psoriasis and other prevalent dermatological conditions. Brickell's executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®. For more information, visit the company's website at www.brickellbio.com
Broadwind Energy Inc. (NASDAQ: BWEN)
Broadwind Energy (NASDAQ: BWEN) is a precision manufacturer of structures, equipment and components for clean tech and other specialized applications. With facilities throughout the U.S., the company's talented team is committed to helping customers maximize performance of their investments—quicker, easier and smarter. Broadwind Energy specializes in the production of wind turbine towers and fabrications for oil and gas, mining and other industrial applications. Highly regarded by customers for flexibility and adaptability, Broadwind specializes in the fabrication of heavier next-generation wind towers that are larger, more technically advanced and designed for multi-megawatt and larger wind turbines. For more information, visit the company's website at www.bwen.com
Burcon NutraScience Corp. (TSX: BU)
Burcon NutraScience (TSX: BU) is a global technology leader in the development of plant-based proteins. With over 270 issued patents and more than 260 additional patent applications, developed over a span of more than 20 years, Burcon has grown an extensive portfolio of composition, application and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods Corporation was established in a joint venture by Burcon and three veteran food industry executives. Merit Foods is building a state-of-the-art protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients. For more information, visit the company's website at www.burcon.ca
CalAmp Corp. (NASDAQ: CAMP)
CalAmp (NASDAQ: CAMP) is a global technology solutions pioneer transforming the mobile connected economy. The company helps reinvent business and improve lives around the globe with technology solutions that streamline complex mobile IoT deployments and bring intelligence to the edge. CalAmp's software and subscription-based services, scalable cloud platform and intelligent devices collect and assess business-critical data from mobile assets and their contents. The company calls this "The New How," facilitating efficient decision making, optimizing mobile asset utilization and improving road safety. Headquartered in Irvine, California, CalAmp has been publicly traded since 1983 and has 20 million products installed and over 1.3 million software and services subscribers worldwide. LoJack®, Tracker™ and Here Comes The Bus® are CalAmp brands. For more information, visit the company's website at www.calamp.com
Callaway Golf Company (NYSE: ELY)
Callaway Golf (NYSE: ELY) is a premium golf equipment and active lifestyle company with a portfolio of global brands, including Callaway Golf, Odyssey, OGIO, TravisMathew and Jack Wolfskin. Through an unwavering commitment to innovation, Callaway manufactures and sells premium golf clubs, golf balls, golf and lifestyle bags, golf and lifestyle apparel and other accessories. For more information, visit the company's website at www.callawaygolf.com
Calyxt Inc. (NASDAQ: CLXT)
Calyxt (NASDAQ: CLXT) is a plant-based technology company that utilizes patented breeding technology to make the food consumers love a healthier choice. The care Calyxt takes extends beyond nutritional value. The company partners with farmers and food companies to deliver traceable plant-based products developed to be healthier and more sustainable than their conventional counterparts. Calyxt uses cutting-edge plant breeding techniques to develop products that help improve diets by reducing bad fats, allergens and toxins. Today, oil from the company's high-oleic soybean plants has lower saturated fats than commodity soybean oil. Calyxt is also developing high-fiber wheat designed to provide an excellent source of daily fiber when incorporated into wheat-based foods. For more information, visit the company's website at www.calyxt.com
Cambium Networks Corp. (NASDAQ: CMBM)
Cambium Networks (NASDAQ: CMBM) is a leading global provider of wireless connectivity solutions that strengthen connections between people, places and things. Specializing in providing an end-to-end wireless fabric of reliable, scalable, secure, cloud-managed platforms that perform under demanding conditions, Cambium Networks empowers service providers and enterprise, industrial and government network operators to build intelligent edge connectivity. Headquartered outside Chicago and with R&D centers in the U.S., U.K. and India, Cambium Networks sells through a range of trusted global distributors. For more information, visit the company's website at www.cambiumnetworks.com
Canadian Solar Inc. (NASDAQ: CSIQ)
Canadian Solar (NASDAQ: CSIQ) was founded in 2001 in Canada and is one of the world's largest and foremost solar power companies. It is a leading manufacturer of solar photovoltaic modules and provider of solar energy solutions and has a geographically diversified pipeline of utility-scale power projects in various stages of development. Over the past 19 years, Canadian Solar has successfully delivered over 38 GW of premium-quality modules to customers in over 150 countries around the world. Canadian Solar is one of the most bankable companies in the solar industry, having been publicly listed on NASDAQ since 2006. For more information, visit the company's website at www.canadiansolar.com
Canterbury Park Holding Corp. (NASDAQ: CPHC)
Canterbury Park (NASDAQ: CPHC) owns and operates Canterbury Park Racetrack and Card Casino in Shakopee, Minnesota, the only thoroughbred and quarter horse racing facility in the state. The company offers live racing from May to September. The Card Casino hosts card games 24 hours a day, seven days a week, dealing both poker and table games. The company also conducts year-round wagering on simulcast horse racing and hosts a variety of other entertainment and special events at its Shakopee facility. The company is redeveloping 140 acres of underutilized land surrounding the racetrack in a project know as Canterbury Commons. The company is pursuing several mixed-use development opportunities for this land, directly and through joint ventures. For more information, visit the company's website at www.canterburypark.com
Carriage Services Inc. (NYSE: CSV)
Carriage Services (NYSE: CSV) is committed to being the most professional, ethical and highest-quality funeral and cemetery service organization in its industry. For more than 28 years, the company has partnered with the best funeral home and cemetery owners in America to provide the most comprehensive succession planning solution. The culture of Carriage Services is one of entrepreneurship, high-performance leadership, ownership and partnership both in principle and in practice at every level. For more information, visit the company's website at www.carriageservices.com
cbdMD Inc. (NYSE: YCBD)
cbdMD (NYSE: YCBD) is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs and CBD pet products. cbdMD is also a proud partner of Bellator MMA, Life Time, Inc., and Supercross and has one of the largest rosters of professional sports athletes who are part of "Team cbdMD." cbdMD offers a comprehensive line of over 100 SKUs of U.S.-produced, THC-free CBD products, and more than 4,000 retail outlets carry cbdMD products. For more information, visit the company's website at www.cbdmd.com
CECO Environmental Corp. (NASDAQ: CECE)
CECO Environmental (NASDAQ: CECE) is a global leader in air quality and fluid handling serving the energy, industrial and other niche markets. Providing innovative technology and application expertise, CECO helps companies grow their business with safe, clean and more efficient solutions that help protect our shared environment. In regions around the world, CECO works to improve air quality, optimize the energy value chain and provide custom-engineered solutions for applications including oil and gas, power generation, water and wastewater, battery production, poly silicon fabrication, chemical and petrochemical processing along with a range of others. For more information, visit the company's website at www.cecoenviro.com
Cellectar Biosciences Inc. (NASDAQ: CLRB)
Cellectar Biosciences (NASDAQ: CLRB) is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company is developing proprietary drugs independently and through research and development collaborations. The company's core objective is to leverage its proprietary Phospholipid Drug Conjugate™ (PDC) delivery platform to develop PDCs that specifically target cancer cells, delivering improved efficacy and better safety as a result of fewer off-target effects. The company's PDC platform possesses the potential for the discovery and development of the next generation of cancer-targeting treatments, and it plans to develop PDCs independently and through research and development collaborations. For more information, visit the company's website at www.cellectar.com
Celsion Corp. (NASDAQ: CLSN)
Celsion (NASDAQ: CLSN) is a fully integrated oncology company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies. The company's lead program is ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in phase 3 development for the treatment of primary liver cancer. The pipeline also includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. Celsion has two platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies. For more information, visit the company's website at www.celsion.com
Celsius Holdings Inc. (NASDAQ: CELH)
Celsius Holdings (NASDAQ: CELH) is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CELSIUS® has four beverage lines that each offer proprietary, functional, healthy-energy formulas clinically proven to offer significant health benefits to its users. The four lines include CELSIUS® Originals, CELSIUS HEAT™, CELSIUS® On-the-Go and CELSIUS® Sweetened with Stevia. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. For more information, visit the company's website at www.celsiusholdingsinc.com
Century Casinos Inc. (NASDAQ: CNTY)
Century Casinos (NASDAQ: CNTY) is an international casino entertainment company that operates worldwide. The company owns and operates Century Casino & Hotels in Cripple Creek and Central City, Colorado, and in Edmonton, Alberta, Canada; the Century Casino in Cape Girardeau and Caruthersville, Missouri, and in Calgary and St. Albert, Alberta, Canada, and in Bath, England; Mountaineer Casino, Racetrack & Resort in New Cumberland, West Virginia; the Century Mile Racetrack and Casino ("CMR") in Edmonton, Alberta, Canada; and Century Bets! Inc. ("CBS"). CBS and CMR operate the pari-mutuel off-track horse betting networks in southern and northern Alberta, respectively. The company has ownership in additional international ventures, operates five ship-based casinos and continues to pursue other projects in various stages of development. For more information, visit the company's website at www.cnty.com
Cerence Inc. (NASDAQ: CRNC)
Cerence (NASDAQ: CRNC) is the global industry leader in creating unique, moving experiences for the automotive world. As an innovation partner to the world's leading automakers, it is helping transform how a car feels, responds and learns. The company's track record is built on more than 20 years of knowledge and almost 325 million cars on the road today. Whether it's connected cars, autonomous driving or e-vehicles, Cerence is mapping the road ahead. For more information, visit the company's website at www.cerence.com
CEVA Inc. (NASDAQ: CEVA)
CEVA (NASDAQ: CEVA) is the leading licensor of wireless connectivity and smart sensing technologies, offering digital signal processors, AI processors, wireless platforms and complementary software for sensor fusion, image enhancement, computer vision, voice input and artificial intelligence, all of which are key enabling technologies for a smarter, connected world. CEVA partners with semiconductor companies and OEMs worldwide to create power-efficient, intelligent and connected devices for a range of end markets, including mobile, consumer, automotive, robotics, industrial and IoT. The company's ultra-low-power IPs include comprehensive DSP-based platforms for 5G baseband processing in mobile and infrastructure, advanced imaging and computer vision for any camera-enabled device and audio/voice/speech and ultra-low power always-on/sensing applications for multiple IoT markets. CEVA's Hillcrest Labs sensor processing technologies provide a broad range of sensor fusion software and IMU solutions for AR/VR, robotics, remote controls, and IoT; it also offers a family of AI processors capable of handling the complete gamut of neural network workloads, on-device. For wireless IoT, CEVA offers the industry's most widely adopted IPs for Bluetooth (low energy and dual mode), Wi-Fi 4/5/6 (802.11n/ac/ax) and NB-IoT. For more information, visit the company's website at www.ceva-dsp.com
Champions Oncology Inc. (NASDAQ: CSBR)
Champions Oncology (NASDAQ: CSBR) is a leading global oncology pharmacology services provider that utilizes its experience in clinically relevant models of cancer and assists biopharmaceutical companies of all sizes across all stages of drug development. The company's mission is to provide translational solutions that enable the assessment of drug effectiveness and identification of relevant patient populations to target in human clinical trials. With an extensive and well-characterized patient-derived xenograft bank across a wide range of indications, Champions is well-positioned to run proof-of-concept, indication expansion and clinical trial simulation studies. Models are available with patient clinical data, including patient treatment and response information, in addition to whole exome and RNA sequencing data. Standard of care responses have also been generated in vivo for a large number of models. For more information, visit the company's website at www.championsoncology.com
Chaparral Energy Inc. (NYSE: CHAP)
Chaparral Energy (NYSE: CHAP) is an independent oil and natural gas exploration and production company headquartered in Oklahoma City, Oklahoma. Founded in 1988, Chaparral is a pure-play operator focused in Oklahoma's STACK/Merge Play, where it has approximately 129,000 net acres primarily in Kingfisher, Canadian and Garfield counties. The company has approximately 218,000 net surface acres in the midcontinent region. For more information, visit the company's website at www.chaparralenergy.com
Charles & Colvard Ltd. (NASDAQ: CTHR)
Charles & Colvard (NASDAQ: CTHR) believes luxury can be beautiful and conscientious. As an e-commerce driven business, the company brings revolutionary gemstones and jewelry to market through the use of innovative technology and direct-to-consumer engagement. Charles & Colvard is the original pioneer of lab-created moissanite, a rare gemstone formed from silicon carbide. Consumers seek Charles & Colvard fashion, bridal and fine jewelry because of its exceptional quality and incredible value and the company's shared beliefs in environmental and social responsibility. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle. For more information, visit the company's website at www.charlesandcolvard.com
Charles River Associates (NASDAQ: CRAI)
Charles River Associates (NASDAQ: CRAI) ("CRA") is a leading global consulting firm specializing in economic, financial and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. For more information, visit the company's website at www.crai.com
Charlotte's Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF)
Charlotte's Web Holdings (TSX: CWEB) (OTCQX: CWBHF) is a market leader in the production and distribution of innovative hemp-derived cannabidiol (CBD) wellness products. The company's premium-quality products start with proprietary hemp genetics that are responsibly manufactured into hemp-derived CBD extracts naturally containing a full spectrum of phytocannabinoids, including CBD, terpenes, flavonoids and other beneficial hemp compounds. Charlotte's Web product categories include CBD oil tinctures (liquid products), CBD capsules, CBD topicals and CBD pet products. Charlotte's Web hemp-derived CBD extracts are sold through select distributors, brick-and-mortar retailers, and online through the company's website. The rate the company pays for agricultural products reflects a fair and sustainable rate driving higher-quality yield, encouraging good farming practices, and supporting U.S. farming communities. For more information, visit the company's website at www.CharlottesWeb.com
Chiasma Inc. (NASDAQ: CHMA)
Chiasma (NASDAQ: CHMA) is focused on improving the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to develop oral medications that are currently available only as injections. In July 2019, the company reported positive topline data from its CHIASMA OPTIMAL phase 3 clinical trial for its octreotide capsules product candidate, conditionally trade named MYCAPSSA, for the maintenance therapy of adult patients with acromegaly in whom prior treatment with somatostatin analogs has been shown to be effective and tolerated. In January 2020, the FDA accepted the company's NDA resubmission seeking marketing approval of MYCAPSSA in the U.S. For more information, visit the company's website at www.chiasma.com
China Online Education Group (NYSE: COE)
China Online Education Group (NYSE: COE) is a leading online education platform in China with core expertise in English education. The company's mission is to make quality education accessible and affordable. The company's online and mobile education platforms enable students across China to take live, interactive English lessons with overseas foreign teachers, on demand. The company connects its students with a large pool of highly qualified foreign teachers that it assembled using a shared economy approach, and the company employs student and teacher feedback and data analytics to deliver a personalized learning experience to its students. For more information, visit the company's website at 51talk.investorroom.com
ChromaDex Corp. (NASDAQ: CDXC)
ChromaDex (NASDAQ: CDXC) is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN® nicotinamide riboside chloride, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®. For more information, visit the company's website at www.chromadex.com
CIM Commercial Trust Corp. (TASE: CMCT-L) (NASDAQ: CMCT)
CIM Commercial Trust (TASE: CMCT-L) (NASDAQ: CMCT) is a real estate investment trust that primarily acquires, owns and operates Class A and creative office assets in vibrant and improving metropolitan communities throughout the United States. Its properties are primarily located in Los Angeles and the San Francisco Bay Area. CIM Commercial Trust is operated by affiliates of CIM Group, L.P., a vertically integrated owner and operator of real assets with multidisciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing and onsite property management capabilities. For more information, visit the company's website at www.cimcommercial.com
Clarus Corp. (NASDAQ: CLAR)
Clarus (NASDAQ: CLAR) is focused on the outdoor and consumer industries, seeking opportunities to acquire and grow businesses that can generate attractive shareholder returns. The company has substantial net operating tax loss carryforwards, which it is seeking to redeploy to maximize shareholder value. Clarus' primary business is as a leading developer, manufacturer and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain and sport markets. The company's products are principally sold under the Black Diamond®, Sierra®, PIEPS®, and SKINourishment® brand names through specialty and online retailers, distributors and original equipment manufacturers throughout the U.S. and internationally. For more information, visit the company's website at www.claruscorp.com
Clearfield Inc. (NASDAQ: CLFD)
Clearfield (NASDAQ: CLFD) designs, manufactures and distributes fiber optic management, protection and delivery products for communications networks. The company's "fiber to anywhere" platform serves the unique requirements of leading incumbent local exchange carriers (traditional carriers), competitive local exchange carriers (alternative carriers), and MSO/cable TV companies, while also catering to the broadband needs of the utility/municipality, enterprise, data center and military markets. Headquartered in Minneapolis, Minnesota, Clearfield deploys more than a million fiber ports each year. For more information, visit the company's website at www.seeclearfield.com
ClearOne Inc. (NASDAQ: CLRO)
ClearOne (NASDAQ: CLRO) is a global company that designs, develops and sells conferencing, collaboration and network streaming solutions for voice and visual communications. The performance and simplicity of its advanced, comprehensive solutions offer unprecedented levels of functionality, reliability and scalability. ClearOne enhances communication and collaboration for organizations worldwide, from the Fortune 500 to small and medium businesses and institutions. The company designs, develops and sells conferencing, collaboration, network streaming and signage solutions through a global network of expert AV and IT practitioners who specify, install and support its advanced hardware, software, apps and cloud solutions. For more information, visit the company's website at www.clearone.com
Clearside Biomedical Inc. (NASDAQ: CLSD)
Clearside Biomedical (NASDAQ: CLSD) is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back-of-the-eye diseases. Clearside's proprietary SCS Microinjector targeting the suprachoroidal space (SCS) offers unique access to the macula, retina and choroid, where sight-threatening disease often occurs. The company's SCS injection platform is an inherently flexible, in-office, nonsurgical procedure intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications as well as future therapeutic innovations such as gene therapy. For more information, visit the company's website at www.clearsidebio.com
CNFinance Holdings Ltd. (NYSE: CNF)
CNFinance (NYSE: CNF) is a leading home equity loan service provider in China. CNFinance facilitates loans by connecting micro- and small-enterprise (MSE) owners with its funding partners. The company's primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. The loans CNFinance facilitated are primarily funded through a trust lending model with its trust company partners, who are well-established with sufficient funding sources and have licenses to engage in lending business nationwide. The company's risk mitigation mechanism is embedded in the design of its loan products, supported by an integrated online and offline process focusing on risks of both borrowers and collateral and further enhanced by effective post-loan management procedures. For more information, visit the company's website at ir.cashchina.cn
CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
CNS Pharmaceuticals (NASDAQ: CNSP) is a biotechnology company specializing in the development of novel treatments for primary and metastatic brain and central nervous system tumors. Its lead candidate, Berubicin, is proposed for the treatment of glioblastoma, a type of brain cancer currently considered incurable, as well as for pancreatic and ovarian cancers, and lymphomas. The company entered into an intellectual property (IP) agreement with Houston Pharmaceuticals, Inc. and a purchase agreement with Reata. For more information, visit the company's website at www.cnspharma.com
Codexis Inc. (NASDAQ: CDXS)
Codexis (NASDAQ: CDXS) is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis' proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, visit the company's website at www.codexis.com
CohBar Inc. (NASDAQ: CWBR)
CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company focused on the research and development of mitochondria-based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. Mitochondria-based therapeutics originate from the discovery by CohBar's founders of a novel group of naturally occurring mitochondrial-derived peptides within the mitochondrial genome that regulate metabolism and cell death and whose biological activity declines with age. To date, the company has discovered more than 100 mitochondrial-derived peptides. CohBar's efforts focus on the development of these peptides into therapeutics that offer the potential to address a broad range of diseases, including nonalcoholic steatohepatitis (NASH), obesity, fibrotic diseases, cancer, Type 2 diabetes, and cardiovascular and neurodegenerative diseases. For more information, visit the company's website at www.cohbar.com
Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP)
Columbia Care (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) is one of the largest fully integrated operators in the global medical cannabis industry, with licenses in 17 jurisdictions in the U.S. and the EU. With over 1.4 million sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation in cannabis, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect. For more information, visit the company's website at www.col-care.com
Compass Diversified Holdings (NYSE: CODI)
Compass Diversified Holdings (NYSE: CODI) owns and manages a diverse family of established North American middle market businesses. Each of its current subsidiaries is a leader in its niche market. CODI maintains controlling ownership interests in each of its subsidiaries in order to maximize its ability to impact long-term cash flow generation and value. The company provides both debt and equity capital for its subsidiaries, contributing to their financial and operating flexibility. CODI utilizes the cash flows generated by its subsidiaries to invest in the long-term growth of the company and to make cash distributions to its shareholders. For more information, visit the company's website at www.compassequity.com
Consolidated Water Co. Ltd. (NASDAQ: CWCO)
Consolidated Water (NASDAQ: CWCO) develops and operates advanced water supply and treatment plants and water distribution systems. The company operates water production facilities in the Cayman Islands, the Bahamas and the British Virgin Islands and operates water treatment facilities in the United States. The company also manufactures and services a wide range of products and provides design, engineering, management, operating and other services applicable to commercial and municipal water production, supply and treatment, and industrial water and wastewater treatment. For more information, visit the company's website at www.cwco.com
Converge Technology Solutions Corp. (TSXV: CTS) (OTCQX: CTSDF) (FSE:0ZB)
Converge Technology Solutions (TSXV: CTS) (OTCQX: CTSDF) (FSE:0ZB) combines innovation accelerators and foundational infrastructure solutions to deliver best‐of‐breed solutions and services to customers. The company is building a platform of regionally focused hybrid IT solution providers to enhance their ability to provide multi‐cloud solutions, blockchain, resiliency and managed services, enabling Converge to address the business and IT issues that public and private‐sector organizations face today. For more information, visit the company's website at convergetp.com
Conversion Labs Inc. (OTCQB: CVLB)
Conversion Labs (OTCQB: CVLB) is a health and wellness focused e-commerce company with a portfolio of online direct-to-consumer brands. The company's portfolio of brands includes proprietary over-the-counter products and prescription medications. The company also provides online virtual physician consultations to consumers in 48 states. In addition to its healthcare platform, Conversion Labs is the majority shareholder of PDF Simpli, a direct-to-consumer SaaS business for editing, signing and sharing PDF documents. For more information, visit the company's website at www.conversionlabs.com
Cooper-Standard Holdings Inc. (NYSE: CPS)
Cooper-Standard (NYSE: CPS) is headquartered in Novi, Michigan, and is a leading global supplier of systems and components for the automotive industry. Products include sealing, fuel and brake delivery and fluid transfer systems. Cooper Standard employs approximately 28,000 people globally and operates in 21 countries around the world. For more information, visit the company's website at www.cooperstandard.com
CoreCivic Inc. (NYSE: CXW)
CoreCivic (NYSE: CXW) is a diversified government solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. The company provides a broad range of solutions to government partners that serve the public good through corrections and detention management, a growing network of residential reentry centers to help address America's recidivism crisis, and government real estate solutions. CoreCivic is a publicly traded real estate investment trust (REIT) and the nation's largest owner of partnership correctional, detention and residential reentry facilities. The company also believes it is the largest private owner of real estate used by U.S. government agencies. For more information, visit the company's website at www.corecivic.com
Corvus Gold Inc. (TSX: KOR) (OTCQX: CORVF)
Corvus Gold (TSX: KOR) (OTCQX: CORVF) is a North American gold exploration and development company focused on its near-term gold-silver mining project at the North Bullfrog and Mother Lode Districts in Nevada. Corvus is committed to building shareholder value through new discoveries and the expansion of its projects to maximize share price leverage in an advancing gold and silver market. For more information, visit the company's website at corvusgold.com
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS)
Corvus Pharmaceuticals (NASDAQ: CRVS) is a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies. Corvus' lead product candidates are ciforadenant (CPI-444), a small molecule inhibitor of the A2A receptor, and CPI-006, a humanized monoclonal antibody directed against CD73 that exhibits immunomodulatory activity and blockade of adenosine production. These product candidates are being studied in ongoing phase 1 and 2 clinical trials in patients with a wide range of advanced solid tumors. The company's third clinical program, CPI-818, an oral, small molecule drug that has been shown to selectively inhibit ITK, is in a multicenter phase 1/1b clinical trial in patients with several types of T-cell lymphomas. For more information, visit the company's website at www.corvuspharma.com
Covanta Holding Corp. (NYSE: CVA)
Covanta (NYSE: CVA) is a world leader in providing sustainable waste and energy solutions. Annually, Covanta's modern Energy-from-Waste ("EfW") facilities safely convert approximately 21 million tons of waste from municipalities and businesses into clean, renewable electricity to power 1 million homes and recycle 500,000 tons of metal. Through a vast network of treatment and recycling facilities, Covanta also provides comprehensive industrial material management services to companies seeking solutions to some of today's most complex environmental challenges. For more information, visit the company's website at www.covanta.com
Cree Inc. (NASDAQ: CREE)
Cree (NASDAQ: CREE) is an innovator of Wolfspeed® power and radio frequency (RF) semiconductors and lighting class LEDs. Cree's Wolfspeed product families include silicon carbide materials, power-switching devices and RF devices targeted for applications such as electric vehicles, fast charging inverters, power supplies, telecom, military and aerospace. Cree's LED product families include blue and green LED chips, high-brightness LEDs and lighting-class power LEDs targeted for indoor and outdoor lighting, video displays, transportation and specialty lighting applications. For more information, visit the company's website at www.cree.com
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)
Cresco Labs (CSE: CL) (OTCQX: CRLBF) is one of the largest vertically integrated multistate cannabis operators in the United States. Cresco is built to become the most important company in the cannabis industry by combining the most strategic geographic footprint with one of the leading distribution platforms in North America. Employing a consumer-packaged goods ("CPG") approach to cannabis, Cresco's house of brands is designed to meet the needs of all consumer segments and includes some of the most recognized and trusted national brands including Cresco, Remedi and Mindy's, a line of edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside, Cresco's national dispensary brand, is a wellness-focused retailer designed to build trust, education and convenience for both existing and new cannabis consumers. For more information, visit the company's website at www.crescolabs.com
Crinetics Pharmaceuticals Inc. (NASDAQ: CRNX)
Crinetics Pharmaceuticals (NASDAQ: CRNX) is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate, paltusotine (formerly CRN00808), is an oral selective nonpeptide somatostatin receptor Type 2 biased agonist undergoing two phase 2 clinical trials for the treatment of acromegaly, an orphan disease affecting more than 25,000 people in the United States. Crinetics' second oral product development candidate, CRN01941, has entered the clinic for the treatment of neuroendocrine tumors. The company is also developing oral nonpeptide somatostatin agonists for hyperinsulinism as well as oral nonpeptide ACTH antagonists for the treatment of Cushing's disease and other diseases of excess ACTH. All of the company's drug candidates are new chemical entities resulting from in-house drug discovery efforts. For more information, visit the company's website at www.crinetics.com
Crown Crafts Inc. (NASDAQ: CRWS)
Crown Crafts (NASDAQ: CRWS) designs, markets and distributes infant, toddler and juvenile consumer products. Founded in 1957, Crown Crafts is one of America's largest producers of infant bedding, toddler bedding, bibs and developmental toys. The company operates through its three wholly owned subsidiaries: NoJo Baby & Kids Inc., Sassy Baby Inc. and Carousel Designs LLC, which market a variety of infant, toddler and juvenile products under company-owned trademarks as well as licensed collections and exclusive private label programs. Sales are made directly to retailers, such as mass merchants, large chain stores and juvenile specialty stores, as well as directly to consumers through www.babybedding.com. For more information, visit the company's website at www.crowncrafts.com
Cryoport Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW)
Cryoport (NASDAQ: CYRX) (NASDAQ: CYRXW) is redefining logistics by providing a platform of temperature-controlled solutions for the life sciences industry, serving the biopharma, human reproductive and animal health markets. The company's mission is to support life and health on Earth by providing reliable and comprehensive solutions for the life sciences through its advanced technologies; global supply chain network; and dedicated scientists, technicians and supporting team of professionals. Through purpose-built proprietary packaging; information technology; smart, sustainable cold chain logistics; and biostorage/biobanking services, Cryoport helps its customers advance life sciences research, support lifesaving advanced therapies and deliver vaccines, protein producing materials and IVF treatments in over 100 countries. For more information, visit the company's website at www.cryoport.com
Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF)
Curaleaf (CSE: CURA) (OTCQX: CURLF) is a leading vertically integrated multistate cannabis operator with a dominant presence on both the East and West coasts of the United States, which is the largest cannabis market in the world. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Strategically positioned in highly populated, limited-license states, the company currently operates in 16 states with 53 dispensaries, 15 cultivation sites and 24 processing sites and employs over 2,200 people across the U.S. For more information, visit the company's website at www.curaleaf.com
CV Sciences Inc. (OTCQB: CVSI)
CV Sciences (OTCQB: CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics. The company's flagship brand of PlusCBD™ Oil products are sold at more than 5,500 retail locations throughout the U.S., and it is the top-selling brand of hemp-derived CBD in the natural product retail channel. CV Sciences' state-of-the-art facility follows all guidelines for Good Manufacturing Practices (GMP), and the company's full-spectrum hemp extracts are processed, produced and tested throughout the manufacturing process to confirm the cannabinoid content meets strict company standards. PlusCBD™ Oil's benefits in healthy people are supported by human clinical research data in addition to three published clinical case studies. For more information, visit the company's website at www.cvsciences.com
Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC)
Cyclacel Pharmaceuticals (NASDAQ: CYCC) is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and DNA damage response biology. The transcriptional regulation program is evaluating fadraciclib as a single agent in solid tumors and in combination with venetoclax in patients with relapsed or refractory AML/MDS and CLL. The DNA damage response program is evaluating an oral combination of sapacitabine and venetoclax in patients with relapsed or refractory AML/MDS. An IST is evaluating an oral combination of sapacitabine and olaparib in patients with BRCA mutant breast cancer. The anti-mitotic program is evaluating CYC140, a PLK1 inhibitor, in advanced leukemias/MDS patients. Cyclacel's strategy is to build a diversified biopharmaceutical business focused in hematology and oncology based on a pipeline of novel drug candidates. For more information, visit the company's website at www.cyclacel.com
CynergisTek Inc. (NYSE: CTEK)
CynergisTek (NYSE: CTEK) is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, and compliance goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS as a top performing firm in healthcare cybersecurity and was awarded the 2019 Top Healthcare Cybersecurity Consultants in Black Book IT Advisory Outcomes Survey. For more information, visit the company's website at www.cynergistek.com
Daqo New Energy Corp. (NYSE: DQ)
Daqo New Energy (NYSE: DQ) is a leading manufacturer of high-purity polysilicon for the global solar PV industry. Founded in 2008, the company is one of the world's lowest cost producers of high-purity polysilicon. Daqo's highly efficient and technically advanced manufacturing facility in Xinjiang, China, currently has a nameplate annual polysilicon production capacity of 70,000 metric tons. For more information, visit the company's website at www.dqsolar.com
Daré Bioscience Inc. (NASDAQ: DARE)
Daré Bioscience (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. The company's mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health and fertility. For more information, visit the company's website at www.darebioscience.com
Darling Ingredients Inc. (NYSE: DAR)
Darling Ingredients (NYSE: DAR) is a global developer and producer of sustainable natural ingredients from edible and inedible bio-nutrients, creating a wide range of ingredients and specialty solutions for customers in the pharmaceutical, food, pet food, feed, technical, fuel, bioenergy and fertilizer industries. With operations on five continents, the company collects and transforms all aspects of animal by-product streams into useable and specialty ingredients, such as collagen, edible fats, feed-grade fats, animal proteins and meals, plasma, pet food ingredients, organic fertilizers, yellow grease, fuel feedstocks, green energy, natural casings and hides. The company also recovers and converts recycled oils (used cooking oil and animal fats) into valuable feed and fuel ingredients and collects and processes residual bakery products into feed ingredients. For additional information, visit the company's website at www.darlingii.com
Delcath Systems Inc. (OTCQB: DCTH)
Delcath Systems (OTCQB: DCTH) is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Decalth' s investigational product – Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) – is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the U.S. In Europe, its system has been commercially available since 2012 under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT), where it has been used at major medical centers to treat a wide range of cancers of the liver. For more information, visit the company's website at www.delcath.com
Delta Apparel Inc. (NYSE: DLA)
Delta Apparel (NYSE: DLA), along with its operating subsidiaries, DTG2Go, LLC, Salt Life, LLC, and M.J. Soffe, LLC, is a vertically integrated, international apparel company that designs, manufactures, sources and markets a diverse portfolio of core activewear and lifestyle apparel products under the primary brands of Salt Life®, COAST®, Soffe®, and Delta. The company is a market leader in the direct-to-garment digital print and fulfillment industry. Delta Apparel specializes in selling casual and athletic products through a variety of distribution channels and tiers. For more information, visit the company's website at www.deltaapparelinc.com
DHI Group Inc. (NYSE: DHX)
DHI Group (NYSE: DHX) is a leading provider of data, insights and employment connections providing specialized services for technology professionals and other select online communities. Employers and recruiters use DHI Group's websites and services to source, hire and connect with the most qualified and highly skilled technology professionals, while professionals use the websites and services to find ideal employment opportunities, relevant job advice and tailored career-related data. For nearly 30 years, DHI Group has built the company on providing employers and professionals with career connections, news, tools and information. Today, DHI Group serves multiple markets in North America, Europe, the Middle East and the Asia Pacific region. For more information, visit the company's website at www.dhigroupinc.com
DiaMedica Therapeutics Inc. (NASDAQ: DMAC)
DiaMedica Therapeutics (NASDAQ: DMAC) is a clinical-stage biopharmaceutical company focused on developing novel recombinant (synthetic) proteins. DiaMedica is using its patented and licensed technologies to establish the company as a leader in the development and commercialization of novel recombinant proteins to treat kidney and neurological diseases. The primary focus is on chronic kidney disease ("CKD") and acute ischemic stroke ("AIS"). DiaMedica is advancing its lead drug candidate, DM199, through clinical trials, as appropriate, to create shareholder value by establishing its clinical and commercial potential as a therapy for AIS and CKD. For more information, visit the company's website at www.diamedica.com
Digi International Inc. (NASDAQ: DGII)
Digi International (NASDAQ: DGII) is a leading global provider of business and mission-critical Internet of Things (IoT) connectivity products and solutions. The company helps its customers create next generation connected products and solutions to deploy, monitor and manage critical communications infrastructures and compliance standards in demanding environments with high levels of security, relentless reliability and bulletproof performance. Founded in 1985, Digi International has helped its customers connect over 100 million things and growing. For more information, visit the company's website at www.digi.com
Digital Turbine Inc. (NASDAQ: APPS)
Digital Turbine (NASDAQ: APPS) works at the convergence of media and mobile communications, connecting top mobile operators, OEMs and publishers with app developers and advertisers worldwide. Its comprehensive Mobile Delivery Platform powers frictionless user acquisition and engagement, operational efficiency and monetization opportunities. Digital Turbine's technology platform has been adopted by more than 30 mobile operators and OEMs worldwide. The company has delivered more than one billion app preloads for tens of thousands advertising campaigns. For more information, visit the company's website at www.digitalturbine.com
DMC Global Inc. (NASDAQ: BOOM)
DMC Global (NASDAQ: BOOM) is a diversified holding company whose innovative businesses provide differentiated products and services to niche industrial and commercial markets around the world. DMC's objective is to identify well-run businesses and strong management teams and support them with long-term capital and strategic, legal, technology and operating resources. The company's approach helps its portfolio companies grow core businesses, launch new initiatives, upgrade technologies and systems to support their long-term strategy, and make acquisitions that improve their competitive positions and expand their markets. DMC's culture is to foster local innovation versus centralized control and stand behind its businesses in ways that truly add value. For more information, visit the company's website at www.dmcglobal.com
DSP Group Inc. (NASDAQ: DSPG)
DSP Group (NASDAQ: DSPG) is a global leader in wireless chipsets for a wide range of smart-enabled devices. The company was founded in 1987 on the principles of experience, insight and continuous advancement which enable the company to consistently deliver next-generation solutions in the areas of voice, audio, video and data connectivity. Experts in voice processing, DSP Group invests heavily in innovation for the smart future, the result is leading-edge semiconductor technology that is enabling its customers to develop a new wave of products that bring enhanced user experiences through innovation, like conversation technology. From mobile phones to VoIP and virtual assistants using cloud-based voice services, DSP Group is the answer to the growing demand for the ever-expanding collection of voice controlled smart devices. For more information, visit the company's website at www.DSPG.com
Dyadic International Inc. (NASDAQ: DYAI)
Dyadic International (NASDAQ: DYAI) is a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products at flexible commercial scales. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to create synergy by leveraging Dyadic's technologies in development and manufacture of biopharmaceuticals. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic vaccines, drugs and other biologic products to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers, and as a result improve access and cost to patients and the healthcare system, and most importantly, save lives. For more information, visit the company's website at www.dyadic.com
Earthstone Energy Inc. (NYSE: ESTE)
Earthstone Energy (NYSE: ESTE) is a growth-oriented, independent energy company engaged in development and operation of oil and natural gas properties. Earthstone Energy pursues a value-driven growth strategy focused on projects that the company believes will generate strong and predictable rates of return and increases in stockholder value. The company believes that it should be the operator of the majority of its properties in order to control costs and direct the efficient development of such properties in an effort to optimize investment returns and profitability. The company's primary assets are located in the Midland Basin of west Texas and the Eagle Ford Trend of south Texas. For more information, visit the company's website at www.earthstoneenergy.com
Eastside Distilling Inc. (NASDAQ: EAST)
Eastside Distilling (NASDAQ: EAST) has been producing high-quality, award-winning craft spirits in Portland, Oregon, since 2008. Over the span of 11 years, Eastside Distilling has developed, matured, perfected or acquired then launched many award-winning spirits while evolving to meet the growing demand for quality products and services associated with the burgeoning craft and premium beverage trade. The company is distinguished by its highly decorated lineup of national brands that include Redneck Riviera, Burnside Bourbons, Hue-Hue Coffee Rum, and Azuñia Tequila. For more information, visit the company's website at www.eastsidedistilling.com
Edesa Biotech Inc. (NASDAQ: EDSA)
Edesa Biotech (NASDAQ: EDSA) is a clinical-stage biopharmaceutical company focused on efficiently developing innovative treatments that address significant unmet medical needs. Edesa's lead product candidate, EB01, is a novel non-steroidal anti-inflammatory molecule (sPLA2 inhibitor) for the treatment of chronic allergic contact dermatitis which has demonstrated statistically significant improvements in multiple clinical studies. A phase 2b clinical study of EB01 was initiated in October 2019. Edesa also intends to expand the utility of its sPLA2 inhibitor technology across multiple indications and expand its portfolio with assets that can drive long-term growth opportunities. For more information, visit the company's website at www.edesabiotech.com
eGain Communications Corp. (NASDAQ: EGAN)
eGain Communications (NASDAQ: EGAN) offers customer engagement solutions to deliver digital transformation for leading brands – powered by virtual assistance, AI, knowledge, and analytics. The company's comprehensive suite of applications helps clients deliver memorable, digital-first customer experiences in an omnichannel world. In 2019, eGain was named one of the top 100 companies that matter in knowledge management by KM World for the 13th year in a row. For more information, visit the company's website at www.egain.com
Eldorado Resorts Inc. (NASDAQ: ERI)
Eldorado Resorts (NASDAQ: ERI) is a leading casino entertainment company that owns and operates twenty-three properties in eleven states, including Colorado, Florida, Illinois, Indiana, Iowa, Louisiana, Mississippi, Missouri, Nevada, New Jersey, and Ohio. In aggregate, Eldorado's properties feature approximately 23,900 slot machines, VLTs and e-tables and approximately 660 table games, and over 11,300 hotel rooms. For more information, visit the company's website at www.eldoradoresorts.com
ElectraMeccanica Vehicles Corp. (SOLO)
ElectraMeccanica Vehicles (NASDAQ: SOLO) is a Canadian designer and manufacturer of electric vehicles. The company's flagship vehicle is the innovative, purpose built, single seat electric vehicle called the SOLO. This vehicle will revolutionize commuting, delivery and shared mobility. The SOLO provides a driving experience that is unique, trendy, fun, affordable and environmentally friendly. InterMeccanica, a subsidiary of ElectraMeccanica, has successfully been building high-end specialty cars for 60 years. For more information, visit the company's website at www.electrameccanica.com
electroCore Inc. (NASDAQ: ECOR)
electroCore (NASDAQ: ECOR) is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company's initial targets are the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. For more information, visit the company's website at www.electrocore.com
Elixinol Global Ltd. (ASX: EXL) (OTCQX: ELLXF)
Elixinol Global (ASX: EXL) (OTCQX: ELLXF) through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary supplements, food and wellness products, as well as the cultivation and manufacture of medicinal cannabis products. Elixinol Global's businesses include: Elixinol USA, a manufacturer and global distributor of industrial hemp-based dietary supplement and skin care products; Hemp Foods Australia, a hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products; and Nunyara which was founded in 2014 to participate in the emerging Australian medicinal cannabis market. For more information, visit the company's website at www.elixinolglobal.com
Emerald Bioscience Inc. (OTCQB: EMBI)
Emerald Bioscience (OTCQB: EMBI) is focused on the discovery, development and commercialization of bioengineered cannabinoid-based therapeutics for significant unmet medical needs in global markets. With proprietary technology licensed from the University of Mississippi, Emerald is developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events. Emerald Bioscience is part of the Emerald Group, which comprises multiple companies focused on developing pharmaceutical, botanical and nutraceutical products providing wellness and medical benefits by interacting with the human body's endocannabinoid system. For more information, visit the company's website at www.emeraldbio.life
Emmaus Life Sciences Inc. (OTCQB: EMMA)
Emmaus Life Sciences (OTCQB: EMMA) is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company's mission is to improve the lives of people in need through the discovery, development and commercialization of innovative treatments and therapies. For more information, visit the company's website at www.emmausmedical.com
Endeavour Silver Corp. (NYSE: EXK)
Endeavour Silver (NYSE: EXK) is a mid-tier precious metals mining company that owns and operates three high-grade, underground, silver-gold mines in Mexico. Endeavour is currently advancing the Terronera mine project toward a development decision and exploring its portfolio of exploration and development projects in Mexico and Chile to facilitate its goal to become a premier senior silver producer. The company's philosophy of corporate social integrity creates value for all stakeholders. For more information, visit the company's website at www.edrsilver.com
Energous Corp. (NASDAQ: WATT)
Energous (NASDAQ: WATT) is leading the next generation of wireless charging – wireless charging 2.0 – with its award-winning WattUp® technology, which supports fast, efficient contact-based charging, as well as charging at a distance. WattUp is a scalable, RF-based wireless charging technology that offers substantial improvements in contact-based charging efficiency, foreign object detection, orientation freedom and thermal performance compared to older, coil-based charging technologies. The technology can be designed into many different sized electronic devices for the home and office, as well as the medical, industrial, retail and automotive industries, and it ensures interoperability across products. Energous received the world's first FCC Part 18 certification for at-a-distance wireless charging, and the company has 220 awarded patents for its WattUp wireless charging technology to-date. For more information, visit the company's website at www.energous.com
Energy Fuels Inc. (NYSE: UUUU)
Energy Fuels (NYSE: UUUU) is the leading U.S. producer of uranium – the fuel for carbon-free, emission-free nuclear energy. Nuclear energy is expected to see strong growth in the coming years, as nations around the world work to provide plentiful and affordable energy, while combating global climate change and air pollution. The company's portfolio is unique, featuring more production capacity, licensed mines and processing facilities, and in-ground uranium resources than any other U.S. producer. Energy Fuels boasts diverse cashflow generating opportunities, including vanadium production and uranium recycling. For more information, visit the company's website at www.energyfuels.com
Enphase Energy Inc. (NASDAQ: ENPH)
Enphase Energy (NASDAQ: ENPH) is a global energy technology company and delivers smart, easy-to-use solutions that manage solar generation, storage and management on one intelligent platform. The company's mission is to bring solar energy to the next level, one where it's ready to meet the energy demands of an entire globe. As Enphase works towards its vision for a solar-powered planet, it vows to never lose sight of the three commitments that have guided the company from the beginning: innovation, quality, and responsibility. For more information, visit the company's website at www.enphase.com
EnviroLeach Technologies Inc. (CSE: ETI) (OTCQB: EVLLF) (FSE:7N2)
EnviroLeach Technologies (CSE: ETI) (OTCQB: EVLLF) (FSE:7N2) is engaged in the development and commercialization of environmentally friendly formulas and technologies for the treatment of materials in the mining and recycling sectors. Using its proprietary non-cyanide, water-based, neutral pH treatment process EnviroLeach extracts precious metals from ores, concentrates, and E-Waste using only FDA approved additives and ambient temperature water. Backed by the momentum of a first-class staff of scientists and engineers, tens of thousands individual assays, independent validations and strategic partners and over $20 million dollars in research and development, EnviroLeach's technology is emerging as a potential new standard for the provision of eco-friendly methods for the hydrometallurgical extraction of precious metals in both the conventional mining and E-Waste sectors. For more information, visit the company's website at enviroleach.com
Envision Solar International Inc. (NASDAQ: EVSI)
Envision Solar International (NASDAQ: EVSI) produces and sells unique and patented sustainable infrastructure products, for electric vehicle charging, energy security and outdoor media, including the EV ARC and the Solar Tree with EnvisionTrak patented solar tracking, SunCharge solar Electric Vehicle Charging, ARC technology energy storage, and EnvisionMedia solar advertising displays. Based in San Diego, the company produces Made in America products. For more information, visit the company's website at www.envisionsolar.com
EnWave Corp. (TSXV: ENW) (FSE: E4U)
EnWave (TSXV: ENW) (FSE: E4U), a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum ("REV™") – an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patent-pending methods for uniformly drying and decontaminating cannabis through the use of REV™ technology, shortening the time from harvest to marketable cannabis products. REV™ technology's commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors, including legal cannabis. EnWave's strategy is to sign royalty-bearing commercial licenses with innovative, disruptive companies in multiple verticals for the use of REV™ technology. The company has signed over 30 royalty-bearing licenses to date. In addition to these licenses, EnWave established a Limited Liability Corporation, NutraDried Food Company, LLC, to manufacture, market and sell all-natural dairy snack products in the United States, including the Moon Cheese® brand. For more information, visit the company's website at www.enwave.net
Epsilon Energy Ltd. (NASDAQ: EPSN)
Epsilon Energy (NASDAQ: EPSN) is a North American on-shore focused independent oil and natural gas company engaged in the acquisition, development, gathering and production of oil and gas reserves. The company's primary areas of operation are the Marcellus basin in northeast Pennsylvania and the Anadarko basin in Oklahoma. Epsilon's assets are concentrated in areas with known hydrocarbon resources, which are conducive to multi-well, repeatable drilling programs. For more information, visit the company's website at www.epsilonenergyltd.com
Escalade Sports Inc. (NASDAQ: ESCA)
Escalade Sports (NASDAQ: ESCA) is a global manufacturer and distributor of sports and outdoor recreational equipment. Leaders in their respective categories, Escalade Sports' brands include Bear® Archery, Bear X™, Trophy Ridge®, Rocket®, SIK® and Cajun Bowfishing™ archery equipment; STIGA® and Ping-Pong® table tennis; Accudart® and Unicorn® darting; Atomic®, Victory Tailgate®, Triumph™ Sports, Viva Sol®, Zume Games® recreational games; DURA™ and Onix® pickleball equipment; Goalrilla™, Goalsetter® residential in-ground basketball systems, Goaliath® and Silverback® residential in-ground and portable basketball goals; Lifeline® and the STEP® fitness products; Woodplay® premium playsets; Vuly™ trampolines; and Cue&Case® - a leader in specialty billiard accessories. Escalade Sports' products are available at sporting goods dealers and independent retailers nationwide. For more information, visit the company's website at www.escaladesports.com
Everi Holdings Inc. (NYSE: EVRI)
Everi Holdings (NYSE: EVRI) is a leading supplier of imaginative entertainment and trusted technology solutions for the casino, interactive, and gaming industry. With a focus on both customers and players, Everi develops entertaining games and gaming machines, gaming systems and services, and is the preeminent and most comprehensive provider of core financial products and services, player loyalty tools and applications, and intelligence and regulatory compliance solutions. Everi's mission is to provide casino operators with games that facilitate memorable player experiences, offer seamless and secure financial transactions for casinos and their patrons, and deliver software tools and applications to improve casino operations efficiencies and fulfill regulatory compliance requirements. Everi provides these products and services in its effort to help make its customers even more successful. For more information, visit the company's website at www.everi.com
Evolution Petroleum Corp. (NYSE: EPM)
Evolution Petroleum (NYSE: EPM) is an independent energy company focused on delivering a sustainable dividend yield to its shareholders through the ownership, management and development of producing oil and gas properties. The company's long-term goal is to build a diversified portfolio of oil and gas assets primarily through acquisition, while seeking opportunities to maintain and increase production through selective development, production enhancement and other exploitation efforts on its properties. Evolution's largest asset is its interest in a CO2 enhanced oil recovery project in Louisiana's Delhi field. For more information, visit the company's website at www.evolutionpetroleum.com
Extreme Networks Inc. (NASDAQ: EXTR)
Extreme Networks (NASDAQ: EXTR) is the industry's first cloud-driven, end-to-end enterprise networking company. The company's best-of-breed technology solutions - from the wireless and IoT edge to the data center - are flexible, agile and secure to accelerate the digital transformation of customers and provide them with the fastest path to the autonomous enterprise. Extreme serves 50,000 customers globally, including half of the Fortune 50 and some of the world's leading names in business, hospitality, retail, transportation and logistics, education, government, healthcare and manufacturing. Founded in 1996, Extreme is headquartered in San Jose, California. For more information, visit the company's website at www.extremenetworks.com
EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG)
EyeGate Pharmaceuticals (NASDAQ: EYEG) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. EyeGate's lead product, Ocular Bandage Gel (OBG), is based on a modified form of the natural polymer hyaluronic acid, which is a gel that possesses unique properties providing hydration and healing when applied to the ocular surface. EyeGate is in the clinic for two different patient populations: photorefractive keratectomy (PRK) surgery to demonstrate corneal wound repair and punctate epitheliopathies (PE), which includes dry eye. The objective of OBG is to re-epithelialize the cornea, reduce the risk of infection, improve symptoms, and improve ocular surface integrity. For more information, visit the company's website at www.eyegatepharma.com
Eyenovia Inc. (NASDAQ: EYEN)
Eyenovia (NASDAQ: EYEN) is a clinical-stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology. Eyenovia's pipeline is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more information, visit the company's website at eyenoviabio.com